Document Detail

MedLine Citation:
PMID:  23288483     Owner:  NLM     Status:  Publisher    
Among African-Americans, the faith community has a long history of providing support to its members. Because African-American men tend to delay and decline traditional depression treatment, the faith community may be an effective source of support. The aim of this study was to determine how a rural African-American faith community describes and perceives experiences of depression among African-American males. A convenience sample of 24 men and women participated in focus groups and interview. Four themes were identified: defining depression, etiology of depression, denial of depression, and effect of masculine roles on depression experience.
Keneshia Bryant; Tiffany Haynes; Nancy Greer-Williams; Mary S Hartwig
Related Documents :
24619823 - Protective effects of social support content and support source on depression and its p...
10348383 - Treatment effects with an adolescent abuse survivor's group.
12661753 - Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-contr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-4
Journal Detail:
Title:  Journal of religion and health     Volume:  -     ISSN:  1573-6571     ISO Abbreviation:  J Relig Health     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985199R     Medline TA:  J Relig Health     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Translational Research Institute KL2 Scholar, College of Nursing, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot #529, Little Rock, AR, 72205, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coarsening dynamics of nanodroplets on topographically structured substrates.
Next Document:  Angiogenesis Inhibitors in the Treatment of Epithelial Ovarian Cancer.